Annotation Detail for PKD1L3
Basic Information
Top
Desease Name |
---|
PSYCH |
Attention deficit hyperactivity disorder and conduct disorder |
Desease Name |
---|
Attention deficit hyperactivity disorder and conduct disorder |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D013752 |
Tetracycline |
Tetracycline results in increased expression of PKD1L3 mRNA | increases expression | 16917069
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
3.03 | 17522070 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
4.67 | 16917069 19224547 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
6.20 | 9884423 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
6.85 | 11026799 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
6.50 | 10903871 |
PharmGKB Accession:PA134907578
Releated disease ID |
Related disease Name |
PA443434 | Arthritis, Rheumatoid |
PA447197 | Attention Deficit Disorder with Hyperactivity |
Releated drug ID |
Related drug Name |
PA450192 | leflunomide |